Feedback

Close

Please tell us what do you think, any kind of feedback is highly appreciated.






Happiness

Success is not the key to happiness. Happiness is the key to success. If you love what you are doing, you will be successful.

Helpfulness

Even if it is a little thing, do something for those who have need of help, something for which you get no pay but the privilege of doing it

Truthfulness

Honesty is the first chapter in the book of wisdom. Everything we hear is an opinion, not a fact. Everything we see is a perspective, not the truth.


Welcome to DelCure


DelCure LifeSciences Ltd. (DLL) is a full scale pharmaceutical company with an aim to bring differentiated high quality products through international collaboration with innovator companies from the USA, Switzerland, and European countries. High quality products are assured from our manufacturing partner of high repute.

Our Vision

To become the most respected, uniquely positioned leading pharmaceutical company in the chosen areas or specialty verticals in India and abroad with distinct value based characteristics.


Purpose, Culture, and Value at DelCure LifeSciences Limited

Team DLL strongly believes in promoting the purpose of Happiness and creating the culture of Helpfulness for DLL family members and the society, with the learning from Mother Nature, promoting sustainability and augmenting life with growth. They firmly believe in the value of Truthfulness. DLL is committed to bring innovative products, introduce new drug delivery systems for the larger benefit of the community.

Testimony to this commitment is evident through the five international collaborations they have with Pharma Base, Switzerland; Amarillo Biosciences, USA; Cymbiotics, USA; Helixor, Germany and many others are under progress.

DLL as a company had entered with 2 major specialties Pediatrics and Orthopaedicsin 2013, backed with a vision to fill existing gaps in the therapeutic sub-segments of Orthopaedic, Pediatrics Respiratory, Otologicals, Nutrition and Dermatology.

Read More


News Feed

Our Blog post image goes here